Answers are grounded in this paper and cite their sources.
Anticholinergic drugs have been proposed as possible acute model for investigating geriatric-associated cognitive deficits, but the interactive effect of muscarinic and nicotinic cholinergic blockade on cognitive processes has yet to be examined. Behavioural performance and P300 event-related potential (ERP) measures were assessed in visual and auditory continuous performance (CPT) takes in 10 young adults before and after the double-blind acute administration of a placebo, a centrally acting nicotinic blocker (20 mg mecamylamine), a centrally acting muscarinic blocker (0·6 mg scopolamine) and a combination dose of mecamylamine and scopolamine. Relative to placebo, single and combined drug administration failed to alter response accuracy, but slowed reaction times in both tasks and decreased subjective alertness. Mecamylamine along significantly reduced P300 amplitudes, but only during the visual CPT. The results are discussed in relation to cholinergic functioning in normal and pathological cognition.
No takes yet. Share an insight, caveat, or question.
Knott et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: